Sensitive, homogeneous, and label-free protein-probe assay for antibody aggregation and thermal stability studies

References

• Ferro A, Boyce M. Biological therapies: a long way on from Jenner. Br J Clin Pharmacol. 2013;76(2):161–11. doi:10.1111/bcp.12202.
   PubMed Web of Science ®Google Scholar
• Strohl WR, Strohl LM. (eds.) Introduction to biologics and monoclonal antibodies. Therapeutic antibody engineering. Elsevier; 2012. 1–595.
   Google Scholar
• Kaplon H, Muralidharan M, Schneider Z, Reichert JM. Antibodies to watch in 2020. MAbs. 2020;12(1):1703531.
   Web of Science ®Google Scholar
• Wang W, Singh SK, Li N, Toler MR, King KR, Nema S. Immunogenicity of protein aggregates—Concerns and realities. Int J Pharm. 2012;431(1–2):1–11. doi:10.1016/j.ijpharm.2012.04.040.
   PubMedGoogle Scholar
• Ratanji KD, Derrick JP, Dearman RJ, Kimber I. Immunogenicity of therapeutic proteins: influence of aggregation. J Immunotoxicol. 2014;11(2):99–109. doi:10.3109/1547691X.2013.821564.
   PubMed Web of Science ®Google Scholar
• Awwad S, Angkawinitwong U. Overview of antibody drug delivery. Pharmaceutics. 2018;10(3):83.
   Google Scholar
• Sequeira JAD, Santos AC, Serra J, Estevens C, Seiça R, Veiga F, Ribeiro AJ. Subcutaneous delivery of biotherapeutics: challenges at the injection site. Expert Opin Drug Deliv. 2019;16(2):143–51. doi:10.1080/17425247.2019.1568408.
   PubMed Web of Science ®Google Scholar
• Medicines Agency E. Committee for Medicinal Products for Human Use (CHMP) Guideline on Immunogenicity assessment of therapeutic proteins. 2017.
   Google Scholar
• Safety and efficacy of immune globulins and Alpha-1 Proteinase Inhibitors | FDA.
   Google Scholar
• Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: pathways, induction factors and analysis. J Pharm Sci. 2009;98(9):2909–34. doi:10.1002/jps.21566.
   PubMed Web of Science ®Google Scholar
• Tamás MJ, Sharma SK, Ibstedt S, Jacobson T, Christen P. Heavy metals and metalloids as a cause for protein misfolding and aggregation. Biomolecules. 2014;4(1):252–67. doi:10.3390/biom4010252.
   PubMedGoogle Scholar
• Bansal R, Gupta S, Rathore AS. Analytical platform for monitoring aggregation of monoclonal antibody therapeutics. Pharm Res. 2019;36(11):152.
   Web of Science ®Google Scholar
• Hong P, Koza S, Bouvier ESP. A review size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. J Liq Chromatogr Relat Technol. 2012;35(20):2923–50. doi:10.1080/10826076.2012.743724.
   PubMed Web of Science ®Google Scholar
• Tan YH, Liu M, Nolting B, Go JG, Gervay-Hague J, Liu GY. A nanoengineering approach for investigation and regulation of protein immobilization. ACS Nano. 2008;2(11):2374–84.
   PubMed Web of Science ®Google Scholar
• Demeule B, Lawrence MJ, Drake AF, Gurny R, Arvinte T. Characterization of protein aggregation: the case of a therapeutic immunoglobulin. Biochim Biophys Acta - Proteins Proteomics. 2007;1774(1):146–53. doi:10.1016/j.bbapap.2006.10.010.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Pardeshi NN, Mulder AM, Mulligan SK, Quispe J, On K, Carragher B, Potter CS, Carpenter JF, Schneemann A. Transmission electron microscopy as an orthogonal method to characterize protein aggregates. J Pharm Sci. 2015;104(2):750–59. doi:10.1002/jps.24157.
   PubMedGoogle Scholar
• Ruggeri FS, Šneideris T, Vendruscolo M, Knowles TPJ. Atomic force microscopy for single molecule characterisation of protein aggregation. Arch Biochem Biophys. 2019;664:134–48. doi:10.1016/j.abb.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Gun’ko VM, Klyueva AV, Levchuk YN, Leboda R. Photon correlation spectroscopy investigations of proteins. Adv Colloid Interface Sci. 2003;105:201–328.
   PubMed Web of Science ®Google Scholar
• Den Engelsman J, Garidel P, Smulders R, Koll H, Smith B, Bassarab S, Seidl A, Hainzl O, Jiskoot W. Strategies for the assessment of protein aggregates in pharmaceutical biotech product development. Pharmaceutical Research. 2011;28(4):920–33. doi:10.1007/s11095-010-0297-1.
   PubMed Web of Science ®Google Scholar
• Long X, Zhang C, Cheng J, Bi S. A novel method for study of the aggregation of protein induced by metal ion aluminum(III) using resonance Rayleigh scattering technique. Spectrochim Acta - Part A Mol Biomol Spectrosc. 2008;69(1):71–77. doi:10.1016/j.saa.2007.03.011.
   PubMedGoogle Scholar
• Penzkofer A, Shirdel J, Zirak P, Breitkreuz H, Wolf E. Protein aggregation studied by forward light scattering and light transmission analysis. Chem Phys. 2007;342(1–3):55–63. doi:10.1016/j.chemphys.2007.09.014.
   Google Scholar
• Alsenaidy MA. Aggregation and conformational stability evaluation of myoglobin in the presence of ionic surfactant. Saudi Pharm J. 2018;26(4):515–19. doi:10.1016/j.jsps.2018.02.005.
   PubMedGoogle Scholar
• Panchal J, Kotarek J, Marszal E, Topp EM. Analyzing subvisible particles in protein drug products: a comparison of Dynamic Light Scattering (DLS) and Resonant Mass Measurement (RMM). AAPS J. 2014;16(3):440–51. doi:10.1208/s12248-014-9579-6.
   PubMed Web of Science ®Google Scholar
• Ahrer K, Buchacher A, Iberer G, Josic D, Jungbauer A. Analysis of aggregates of human immunoglobulin G using size-exclusion chromatography, static and dynamic light scattering. J Chromatogr A. 2003;1009(1–2): 89–96.
   PubMed Web of Science ®Google Scholar
• Hall D, Zhao R, Dehlsen I, Bloomfield N, Williams SR, Arisaka F, Goto Y, Carver JA. Protein aggregate turbidity: simulation of turbidity profiles for mixed-aggregation reactions. Anal Biochem. 2016;498:78–94. doi:10.1016/j.ab.2015.11.021.
   PubMed Web of Science ®Google Scholar
• Hawe A, Kasper JC, Friess W, Jiskoot W. Structural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress. Eur J Pharm Sci. 2009;38(2):79–87. doi:10.1016/j.ejps.2009.06.001.
   PubMed Web of Science ®Google Scholar
• Padmanaban A, Menon S Characterization of mAb aggregation.
   Google Scholar
• Oshinbolu S, Shah R, Finka G, Molloy M, Uden M, Bracewell DG. Evaluation of fluorescent dyes to measure protein aggregation within mammalian cell culture supernatants. J Chem Technol Biotechnol. 2018;93(3):909–17. doi:10.1002/jctb.5519.
   PubMedGoogle Scholar
• McClure SM, Ahl PL, Blue JT. High Throughput Differential Scanning Fluorimetry (DSF) formulation screening with complementary dyes to assess protein unfolding and aggregation in presence of surfactants. Pharm Res. 2018;35(4):81.
   Web of Science ®Google Scholar
• Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc. 2007;2(9):2212–21.
   PubMed Web of Science ®Google Scholar
• Hawe A, Sutter M, Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res 2008;25(7):1487–99.
   PubMed Web of Science ®Google Scholar
• He F, Phan DH, Hogan S, Bailey R, Becker GW, Narhi LO, Razinkov VI. Detection of IgG aggregation by a high throughput method based on extrinsic fluorescence. J Pharm Sci. 2010;99(6):2598–608. doi:10.1002/jps.22036.
   PubMedGoogle Scholar
• A NOVEL PROTEIN AGGREGATION ASSAY FOR BIOLOGICS FORMULATION STUDIES AND Production QA/QC ProteoStat® fluorescent reagent for microplate-based aggregate quantitation. 2011.
   Google Scholar
• Niedziela-Majka A, Kan E, Weissburg P, Mehra U, Sellers S, Sakowicz R. High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody. J Biomol Screen. 2015;20(4):552–59.
   PubMedGoogle Scholar
• Vuorinen E, Valtonen S, Eskonen V, Kariniemi T, Jakovleva J, Kopra K, Härmä H. Sensitive Label-Free Thermal Stability Assay for Protein Denaturation and Protein–Ligand Interaction Studies. Anal Chem. 2020;92(5):3512–16. doi:10.1021/acs.analchem.9b05712.
   PubMedGoogle Scholar
• Valtonen S, Vuorinen E, Kariniemi T, Eskonen V, Le Quesne J, Bushell M, Härmä H, Kopra K. Nanomolar Protein–Protein interaction monitoring with a label-free Protein-Probe technique. Anal Chem. 2020;92(24):15781–88.
   Web of Science ®Google Scholar
• Shang Y, Mernaugh R, Zeng X. Characterization of the native and denatured herceptin by enzyme linked immunosorbent assay and quartz crystal microbalance using a high-affinity single chain fragment variable recombinant antibody. Anal Chem. 2012;84(19):8164–70.
   PubMed Web of Science ®Google Scholar
• Akazawa-Ogawa Y, Nagai H, Hagihara Y. Heat denaturation of the antibody, a multi-domain protein. Biophys Rev.2018;10(2):255–58. doi:10.1007/s12551-017-0361-8.
   Google Scholar
• Pihlasalo S, Kirjavainen J, Hänninen P, Härmä H. High sensitivity luminescence nanoparticle assay for the detection of protein aggregation. Anal Chem. 2011;83(4):1163–66.
   PubMed Web of Science ®Google Scholar
• Mahler HC, Müller R, Frieß W, Delille A, Matheus S. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. Eur J Pharm Biopharm. 2005;59(3):407–17. doi:10.1016/j.ejpb.2004.12.004.
   PubMed Web of Science ®Google Scholar
• Vuorinen E, Valtonen S, Hassan N, Mahran R, Habib H, Malakoutikhah M, Kopra K, Härmä H. Protease substrate-independent universal assay for monitoring digestion of native unmodified proteins. Int J Mol Sci. 2021;22(12):6362.
   PubMed Web of Science ®Google Scholar
• Pérez LM, Rodríguez Taño A de la C, Martín MLR, Gómez PJA, Garay AV, Santana RB. Conformational characterization of a novel anti-HER2 candidate antibody. PLoS One. 2019;14(5):e0215442.
   Web of Science ®Google Scholar
• Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies—Application of platform approaches. J Chromatogr B Anal Technol Biomed Life Sci. 2007;848(1):28–39. doi:10.1016/j.jchromb.2006.09.026.
   PubMed Web of Science ®Google Scholar
• Jin W, Xing Z, Song Y, Huang C, Xu X, Ghose S, Li ZJ. Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification. MAbs. 2019;11(8):1479–91.
   PubMed Web of Science ®Google Scholar
• Horn J, Jena S, Aksan A, Friess W. Freeze/thaw of IGG solutions. Eur J Pharm Biopharm 2019;134:185–89.
   PubMed Web of Science ®Google Scholar
• Gervasi V, Dall Agnol R, Cullen S, McCoy T, Vucen S, Crean A. Parenteral protein formulations: an overview of approved products within the European Union. Eur J Pharm Biopharm. 2018;131:8–24. .
   PubMed Web of Science ®Google Scholar
• Fesinmeyer RM, Hogan S, Saluja A, Brych SR, Kras E, Narhi LO, Brems DN, Gokarn YR. Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies. Pharm Res. 2009;26(4):903–13.
   PubMed Web of Science ®Google Scholar
• Bam NB, Cleland JL, Yang J, Manning MC, Carpenter JF, Kelley RF, Randolph TW. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci. 1998;87(12):1554–59.
   PubMed Web of Science ®Google Scholar